International Journal of Breast Cancer (Jan 2024)

Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients

  • İrem Peker Eyüboğlu,
  • Sinan Koca,
  • Betül Çelik,
  • Gökçe Güllü Amuran,
  • M. Ümit Uğurlu,
  • Özkan Alan,
  • Tuğba Akın Telli,
  • Perran Fulden Yumuk,
  • Mustafa Akkiprik

DOI
https://doi.org/10.1155/2024/6117394
Journal volume & issue
Vol. 2024

Abstract

Read online

Conclusion: Our study suggests that telomere length in cfDNA may be a useful biomarker for predicting therapy response and possible reoccurrence of the disease in breast cancer patients.